Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Tumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2015 by Thomas Jefferson University
Information provided by (Responsible Party):
Thomas Jefferson University Identifier:
First received: January 17, 2012
Last updated: March 17, 2015
Last verified: March 2015
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2018
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)